FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

39043611000001103: Jyseleca 100mg tablets (Galapagos Biotech Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Oct 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2187841000001115 Jyseleca 100mg tablets (Galapagos Biotech Ltd) 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2187851000001117 Jyseleca 100mg tablets (Galapagos Biotech Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Jyseleca 100mg tablets (Galapagos Biotech Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Jyseleca 100mg tablets (Galapagos Biotech Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Jyseleca 100mg tablets (Galapagos Biotech Ltd) 30 tablet Is a Filgotinib 100mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Jyseleca 100mg tablets (Galapagos Biotech Ltd) 30 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Jyseleca 100mg tablets (Galapagos Biotech Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Jyseleca 100mg tablets (Galapagos Biotech Ltd) 30 tablet Has AMP Jyseleca 100mg tablets (Galapagos Biotech Ltd) true Inferred relationship Existential restriction modifier
Jyseleca 100mg tablets (Galapagos Biotech Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Filgotinib true Inferred relationship Existential restriction modifier
Jyseleca 100mg tablets (Galapagos Biotech Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Jyseleca 100mg tablets (Galapagos Biotech Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Jyseleca 100mg tablets (Galapagos Biotech Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Jyseleca 100mg tablets (Galapagos Biotech Ltd) 30 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Jyseleca 100mg tablets (Galapagos Biotech Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Jyseleca 100mg tablets (Galapagos Biotech Ltd) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Jyseleca 100mg tablets (Galapagos Biotech Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Jyseleca 100mg tablets (Galapagos Biotech Ltd) 30 tablet Has specific active ingredient Filgotinib maleate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start